BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17011336)

  • 1. Compliance with guidelines for ADHD: a pilot study of an evaluation tool.
    Vreeman RC; Madsen KA; Vreeman DJ; Carroll AE; Downs SM
    J Pediatr; 2006 Oct; 149(4):568-71. PubMed ID: 17011336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the diagnosis and treatment of children with attention deficit hyperactivity disorder in Spain using the Achievable Benchmarks of Care (ABC) technique].
    Martínez-Bermejo A; Moreno-Pardillo DM; Soler-López B
    Rev Neurol; 2008 Nov 1-15; 47(9):451-6. PubMed ID: 18985593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of attention-deficit/hyperactivity disorder in rural primary care: the portability of the American Academy of Pediatrics guidelines to the "real world".
    Polaha J; Cooper SL; Meadows T; Kratochvil CJ
    Pediatrics; 2005 Feb; 115(2):e120-6. PubMed ID: 15687419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telemedicine and adherence to national guidelines for ADHD evaluation: a case study.
    Nelson EL; Duncan AB; Peacock G; Bui T
    Psychol Serv; 2012 Aug; 9(3):293-7. PubMed ID: 22867121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Pliszka S;
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):894-921. PubMed ID: 17581453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nurse-led ADHD service for children and adolescents.
    Brown G; Bruce K
    Nurs Times; 2004 Oct 5-11; 100(40):36-8. PubMed ID: 15526569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should we evaluate and treat ADHD in children and adolescents?
    Ambalavanan G; Holten KB
    J Fam Pract; 2005 Dec; 54(12):1058-9. PubMed ID: 16321344
    [No Abstract]   [Full Text] [Related]  

  • 11. Medication adherence in psychopharmacologically treated adults with ADHD.
    Safren SA; Duran P; Yovel I; Perlman CA; Sprich S
    J Atten Disord; 2007 Feb; 10(3):257-60. PubMed ID: 17242421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of pediatric attention deficit/hyperactivity disorder for the general psychiatrist.
    Kratochvil CJ; Vaughan BS; Barker A; Corr L; Wheeler A; Madaan V
    Psychiatr Clin North Am; 2009 Mar; 32(1):39-56. PubMed ID: 19248915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians.
    Epstein JN; Langberg JM; Lichtenstein PK; Mainwaring BA; Luzader CP; Stark LJ
    Pediatrics; 2008 Jul; 122(1):19-27. PubMed ID: 18595982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatricians need more help with ADHD diagnostic guidelines.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(16):1, 5-6. PubMed ID: 15334731
    [No Abstract]   [Full Text] [Related]  

  • 16. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of features of attention deficit hyperactivity disorder in a special school in Ireland.
    Buckley S; Hillery J; Guerin S; McEvoy J; Dodd P
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):156-62. PubMed ID: 18197954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulants, ADHD, and the heart.
    Ganiats TG
    Am Fam Physician; 2009 May; 79(10):846, 851. PubMed ID: 19496384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.